Role of infection in the pathogenesis of obesity;Úloha infekce v patogenezi obezity

Casopis Lekaru Ceskych

Volumn 151, Issue 12, 2012, Pages 563-567

  Hainer, Vojtěch ^a   Hainerová, Irena Aldhoon ^a,b   Zamrazilová, Hana ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adenovirus AD 36; Diabetes mellitus; Infection; Insulin sensitivity; Lipid profile; Obesity

Indexed keywords

ADENOVIRUS INFECTION; ANIMAL; HUMAN; INFECTION; MICROBIOLOGY; OBESITY; REVIEW; RISK FACTOR; VIROLOGY;

ADENOVIRIDAE INFECTIONS; ANIMALS; HUMANS; INFECTION; OBESITY; RISK FACTORS;

EID: 84883861525     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hainer V, Bendlová B. Etiopatogeneze obezity. In: Hainer V, et al. Základy klinické obezitologie. Praha: Grada Publishing 2011; 59-90.
2. Mc Allister E, et al. Ten putative contributors to obesity epidemic. Crit Rev Food Sci Nutr 2009; 49(10): 868-913.
3. Dhurandar NV. Infectobesity: Obesity of infectious origin. J Nutr 2001; 131: 2794S-2797S.
4. Lyons MJ, et al. A virally induced obesity in mice. Science 1982; 216: 82-85.
5. Bernard A, et al. Alteration of leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus. J Virology 1999; 73: 7317-7327. (Pubitemid 29383214)
6. Griffond D, et al. Specific alteration of the expression of selected hypothalamic neuropetides during acute and late mouse brain infection using a morbilli virus: relevance to the late-onset obesity? Brain Res 2004; 1022: 173-181.
7. Carter JK, et al. Rous-associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity. Infect Immun 1983; 39: 410-422. (Pubitemid 13212544)
8. Gosztonyi G, Ludwig H. Borna disease - neuropathology and pathogenesis. Curr Top Microbiol Immunol 1995; 190: 39-73.
9. KimYS, et al. Scrapie-induced obesity in mice. J Infect Dis 1987; 156: 402-405. (Pubitemid 17098212)
10. Kim YS, et al. Adrenal involvement in scarpie-induced obesity. Proc Soc Exp Biol Med 1988; 189: 21-27.
11. Dhurandhar NV, et al. Avian adenovirus leading to pathognomic obesity in chickens. J Bombay Vet College 1990; 2: 131-132.
12. Dhurandhar NV, et al. Effect of adenovirus infection on adiposity in chickens. Vet Microbiol 1992; 31: 101-107.
13. Wigand R, et al. New human adenovirus (candidate adenovirus 36), a novel member of subgroup D. Arch Virol 1980; 64: 225-233. (Pubitemid 10050509)
14. Dhurandhar NV, et al. Adiposity in animals due to a human virus. In J Obes Relat Metab Disord 2000; 24: 989-996. (Pubitemid 30618118)
15. Dhurandhar NV, et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr 2002; 132: 3155-3160.
16. Dhurandhar NV, et al. Transmisibility of adenovirus-induced adiposity in a chicken model. In J Obes 2001; 25: 990-996. (Pubitemid 32566053)
17. Švestka T, et al. Problematika infekce Helicobacter pylori u chorob žaludku a duodena. Čas. Lék. čes. 2004; 143: 734-737. (Pubitemid 39564014)
18. Fixa B. Úvahy o poklesu prevalence infekce Helicobacter pylori a vředové choroby v posledních dvou dekádách. Čas. Lék. čes. 2011; 150(2): 91-93.
19. Švestka T. Léčba infekce Helicobacter pylori u vředové choroby žaludku a duodena. Čas. Lék. čes. 2003; 142: 483-486. (Pubitemid 37093004)
20. Dart AM, et al. Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Int J Obes Relat Metab Disord 2002; 26: 464-468. (Pubitemid 34407258)
21. Jaworowska A, Bazylak G. Chlamydophila pneumoniae antibodies may be independently associated with increased BMI and percentage of body fat among women. Int J Obes (Lond) 2011; 35: 1225-1232.
22. Ekesbo R, et al. Combined seropositivity for H. pylori and C. pneumoniae is associated with age, obesity and social factors. J Cardiovasc Risk 2000; 7: 191-195. (Pubitemid 30463748)
23. Thjodleifsson B, et al. Infections and obesity: A multinational epidemiological study. Scand J Infect Dis 2008; 40: 381-386. (Pubitemid 351566564)
24. Lajunen T, et al. The association of body mass index, waist and hip circumference and waist-hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966. Int J Obes (Lond) 2011; 35: 1470-1478.
25. Bil-Lula ID, et al. Improved real-time PCR assay for detection and quantification of 54 known types of human adenoviruses in clinical samples. Med Sci Monit 2012; 18: BR221-226.
26. de Jong JC, et al. Adenovirus 37: Identification and characterization of a medically important new adenovirus type of subgroup D. J Med Virol 1981; 7: 105-118. (Pubitemid 11067758)
27. Dhurandhar NV, et al. Association of adenovirus infection with human obesity. Obes Res 1997; 5: 464-469. (Pubitemid 127702703)
28. Atkinson RL, et al. Human adenovirus AD-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281-286. (Pubitemid 40333226)
29. Trovato GM, et al. Human obesity relationship with obesity and insulin resistance. Int J Obes (Lond) 2009; 33: 1402-1409.
30. Trovato GM, et al. AD36 adipogenic adenovirus in human nonalcoholic fatty liver disease. Liver Int 2010; 30(2): 184-190.
31. Atkinson RL, et al. Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes 2010; 5(2): 157-160.
32. Gabbert C, et al. Adenovirus 36 and obesity in children and adolescents. Pediatrics 2010; 126: 721-726.
33. Na HN, et al. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 2010; 34: 89-93.
34. Atkinson RL. Human adenovirus-36 and childhood obesity. Int J Pediatr Obes 2011; 6(Suppl1): 2-6.
35. Broderick MP, et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personal. Int J Obes (Lond) 2010; 34: 302-308.
36. Goossens VJ, et al. Lack of evidence for the role of human adenovirus- 36 in obesity in a European cohort. Obesity (Silver Spring) 2011; 19: 220-221.
37. Atkinson RL. Prevalence of infection with adenovirus-36 in Belgium and Holland and association with obesity. Obesity (Silver Spring) 2011; 19(1): 2.
38. Salehian B, et al. Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity. Emerg Infect Dis 2010; 16: 850-852.
39. Vangipuram SD, et al. A human adenovirus enhances preadipocyte differentiation. Obes Res 2004; 12: 770-777. (Pubitemid 41127312)
40. Pasarica M, et al. Adipogenic human adenovirus AD-36 induces commitment, differentiation, and lipid accumulation in human adipose- derived stem cells. Stem Cells 2008; 26: 969-978.
41. Rathod MA, et al. Adipogenic cascade can be induced without adipogenic media by a human adenovirus Obesity (Silver Spring) 2009; 17: 657-664.
42. Rogers PM, et al. Human adenovirus Ad-36 induces adipogenesis via its E4 orf-1 gene. Int J Obes (Lond) 2008; 32: 397-406. (Pubitemid 351414816)
43. Bouwman JJM, et al. Infection-induced inflammatory response of adipocytes in vitro. Int J Obes (Lond) 2008; 32: 892-901. (Pubitemid 351986227)
44. Na HN, Nam JH. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Dis 2012; 205: 914-922.
45. Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002; 967: 379-388. (Pubitemid 34721923)
46. Vangipuram SD, et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 2007; 31: 87-96. (Pubitemid 46006020)
47. Pasarica M, et al. Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring) 2006; 14: 1905-1913. (Pubitemid 46121920)
48. Krishnapuram R, et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779-E789.
49. Dhurandhar EJ, et al. E4orf1: a novel ligand that improves glucose disposal in cell culture. PLoS One 2011; 6: e23394.
50. Trovato GM, et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci 2012; 57: 535-544.
51. Krishnapuram R, et al. Insulin receptor-independent upregulation of cellular glucose uptake. Int J Obes (Lond) 2012 Feb 7 (Epub ahead of print).
52. Trovato GM, et al. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease. J Clin Gastroenterol 2012; 46: e46-e54.
53. Wang ZQ, et al. Human adenovirus type 36 enhances glucose uptake in diabetic and nondiabetic human skeletal muscle cells independent of insulin signaling. Diabetes 2008; 57: 1805-1813.
54. Nedvídková J, et al. Adiponectin, an adipocyte-derived protein. Physiol Res 2005; 54(2): 133-140. (Pubitemid 40686259)
55. Rogers PM, et al. Metabolically favorable remodelling of human adipose tissue by human adenovirus type 36. Diabetes 2008; 57: 2321-2331.